Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Stryker
SYK
$129B
| $217M | 0.27% |
1,301,567
+1,298,901
| +48,721% | +$254M |
|
77
Starbucks
SBUX
$120B
| $214M | 0.27% |
3,261,937
+3,253,109
| +36,850% | +$263M |
|
78
Invesco QQQ Trust
QQQ
$479B
| $214M | 0.26% |
1,121,355
-1,262
| -0.1% | -$267K |
|
79
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.13B
| $213M | 0.26% |
4,254,073
-61,056
| -1% | -$3.1M |
|
80
Petrobras
PBR
$119B
| $208M | 0.26% |
37,892,571
+3,309,297
| +10% | +$39.5M |
|
81
Itaú Unibanco
ITUB
$90.2B
| $199M | 0.25% |
60,917,033
-4,860,009
| -7% | -$24.9M |
|
|
82
Johnson & Johnson
JNJ
$619B
| $195M | 0.24% |
1,484,154
-10,612,976
| -88% | -$1.51B |
|
|
BBL
83
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $184M | 0.23% |
6,064,931
+173,140
| +3% | +$6.82M |
|
|
84
Pfizer
PFE
$149B
| $178M | 0.22% |
5,742,357
-42,083,075
| -88% | -$1.43B |
|
85
SLB Ltd
SLB
$76.5B
| $172M | 0.21% |
12,752,615
+440,090
| +4% | +$12.7M |
|
86
Banco Bradesco
BBD
$37.1B
| $172M | 0.21% |
56,393,255
-4,324,255
| -7% | -$22.2M |
|
|
87
Procter & Gamble
PG
$342B
| $165M | 0.2% |
1,498,636
-3,654,398
| -71% | -$439M |
|
88
Pinduoduo
PDD
$129B
| $149M | 0.18% |
+4,121,835
| New | +$150M |
|
89
NetEase
NTES
$83.5B
| $144M | 0.18% |
2,235,575
-1,485,665
| -40% | -$97.7M |
|
90
Vanguard S&P 500 ETF
VOO
$1.01T
| $141M | 0.17% |
594,652
+28,311
| +5% | +$7.93M |
|
91
ConocoPhillips
COP
$140B
| $141M | 0.17% |
4,570,484
+261,202
| +6% | +$13.3M |
|
92
Credicorp
BAP
$31.2B
| $140M | 0.17% |
981,151
-55,624
| -5% | -$10.5M |
|
93
Lam Research
LRCX
$383B
| $130M | 0.16% |
5,421,210
+5,411,160
| +53,842% | +$156M |
|
94
Baidu
BIDU
$37.1B
| $129M | 0.16% |
1,282,987
-205,047
| -14% | -$25M |
|
95
Chemed
CHE
$7.18B
| $126M | 0.16% |
291,998
-4,537
| -2% | -$2.03M |
|
|
STMP
96
DELISTED
Stamps.com, Inc.
STMP
| $124M | 0.15% |
956,110
-123,523
| -11% | -$12.9M |
|
|
SIVB
97
DELISTED
SVB Financial Group
SIVB
| $118M | 0.15% |
781,152
-57,600
| -7% | -$12.7M |
|
98
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
| $118M | 0.15% |
38,421,423
-14,720,672
| -28% | -$70M |
|
99
ASE Group
ASX
$81.9B
| $116M | 0.14% |
30,932,312
-1,502,958
| -5% | -$7.04M |
|
100
Weibo
WB
$1.94B
| $116M | 0.14% |
3,489,895
-141,848
| -4% | -$6.01M |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.